NASD · Healthcare · Biotechnology · Australia
Immuron Limited ADR is a micro cap company (market value under $300 million) in the Biotechnology industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Immuron Limited ADR stock.
Undervalued: intrinsic value $3.46 per share, market price $0.88, margin of safety 74.6% (as of 2026-10-30).
A 4.2x revenue multiple, discounted for its losses, values the shares at $3.46; the price of $0.88 is 75% below that value.
Leak Score: 69/100 on 8 of 12 signals (Faint Leak).
IMRN is undervalued (as of the 2026-10-30 close). A 4.2x revenue multiple, discounted for its losses, values the shares at $3.46; the price of $0.88 is 75% below that value.
$3.46 per share (as of the 2026-10-30 close), against a market price of $0.88. That is a margin of safety of 74.6%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
69 out of 100, which we rate "Faint Leak", on 8 of 12 value investing signals.